New psoriasis drug approved by Health CanadaHealth Canada has approved SOTYKTU (deucravacitinib tablets), a new psoriasis medication. It’s the first TYK2 inhibitor to be approved in Canada. Do ethics change based on the number of legs involved?Dr. Gary Kinney wonders whether the sacred bug is still worth squashing sometimes. Is cannabis worse for the lungs than tobacco? A uOttawa study found cannabis smokers saw higher rates of several different lung problems than those who smoke cigarettes alone. France lawmakers adopt enshrining abortion in constitution Over 80% of the French population supports the right to abortion. Use of alirocumab to reduce the risk of a major adverse cardiovascular event New pediatric guidelines for toddler screen use stresses quality instead of quantity No screens at all for kids younger than age two, says Canadian Paediatric Society. Sumatriptan identified as highest-risk drug leading to acute angle-closure glaucoma Large Korean study pinpoints 61 drugs associated with acute angle-closure glaucoma. New research identifies tick-borne pathogens spreading outside their normal range Ontario, Quebec Pathogens causing babesiosis and Rocky Mountain spotted fever among those found. Cancer prevalence on the rise in Canada shows special report Lung cancer is the most commonly diagnosed and deadliest, shows data collected over 25 years. Many seniors have a vitamin B12 deficiency: study Researchers suggest simple—but specific—dietary changes would help. First Previous 81 82 83 84 85 Next Last
